SPONSOR
Diakonos Oncology Corporation
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Refractory Melanoma
Diakonos Oncology Corporation is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Refractory Melanoma.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Diakonos Oncology Corporation
How many clinical trials has Diakonos Oncology Corporation sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Diakonos Oncology Corporation, of which 1 are actively recruiting participants. These trials cover conditions including Refractory Melanoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Diakonos Oncology Corporation research focus on?
Diakonos Oncology Corporation clinical trials span Refractory Melanoma. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Diakonos Oncology Corporation clinical trial?
To participate in a Diakonos Oncology Corporation trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Diakonos Oncology Corporation trials with current recruitment status updated daily.
Clinical Trials by Diakonos Oncology Corporation
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology